Perspectives
Pharmacist intervention may help identify potential opioid abuse early
Concurrent drug utilization review catches opioid abuse upstream
July 21, 2016Concurrent drug utilization review (DUR) may cast wider net for catching potential opioid abuse upstream
A pharmacist intervention (DUR) may impact potential opioid misuse and abuse. This study identified at-risk members at the time they submit their opioid prescription. A soft edit (point of service) intervention delayed or altered claims for 42% of the members in the study.
Related news
Perspectives
August 28, 2024
Clinical News: August 2024
Your monthly source for drug information highlights
Perspectives
August 28, 2024
Drug Approvals Monthly Update: August 2024
This monthly update of United States (U.S.) Food and Drug Administration (FDA) approvals…
Perspectives
August 27, 2024
Expert Clinical Network Insights: August 2024
A look into our Expert Clinical Network (ECN) — part of Prime/MRx’s value-based approach to medical and pharmacy benefit management that offers access to more than 175 national and world-renowned key opinion leaders in multiple disease categories who provide expertise on challenging prior authorization case reviews, peer-to-peer discussions, drug policy development and formulary guidance